Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

American Family Physician January 1, 2004 Lin & Kirchner	Hepatitis B Hepatitis B causes significant morbidity and mortality worldwide. Effective vaccines for hepatitis B virus have been available since 1982; infant and childhood vaccination programs introduced in the 1990s have resulted in a marked decrease in new infections.
American Family Physician October 15, 2005 John G. Beauman	Genital Herpes: A Review Genital herpes simplex virus infection is a recurrent, lifelong disease with no cure. The strongest predictor for infection is a person's number of lifetime sex partners. Counseling patients about the risk of transmission is crucial and helps prevent the spread of disease and neonatal complications.
American Family Physician August 15, 2005 Ward & Kugelmas	Using Pegylated Interferon and Ribavirin to Treat Patients with Chronic Hepatitis C New treatment regimens and advances in the management of side effects and toxicities have expanded the pool of patients who can be treated with pegylated interferon and ribavirin.
Nurse Practitioner December 2009 Gujral & Collantes	Understanding Viral Hepatitis: A guide for primary care Recent advancements in the field of genomics and proteomics technology have given researchers and clinicians more insight on disease pathogenesis and helped create more tailored approaches to the treatment of these conditions.
American Family Physician December 15, 2003 Monika N. Daftary	Adefovir (Hepsera) for Chronic Hepatitis B Infection Adefovir offers an effective first-line alternative for the treatment of chronic hepatitis B. It also may prove to be useful in patients who have failed therapy with lamivudine as well as in patients who have difficulty tolerating interferon alfa-2b.
American Family Physician March 15, 2004	Management of Hepatitis C: Evaluating Suitability for Drug Therapy Chronic hepatitis C virus infection is a common and serious disease. Although an estimated 2.7 million persons in the United States have this disease, most have not yet been diagnosed.
Nursing December 2008 Susan Simmons Holcomb	Caring for a patient with chronic hepatitis C Teach your patient about improved treatments that can help him deal with this potentially deadly infection.
Nurse Practitioner July 2010 Christine S. Brennan	Overcoming barriers to new treatment options for hepatitis C This article reviews current guidelines for HCV treatment and proposes strategies to overcome potential barriers to state-of-the-art therapy.
American Family Physician September 15, 2005 Mounsey, Matthew & Slawson	Herpes Zoster and Postherpetic Neuralgia: Prevention and Management The recognizable appearance and the dermatomal distribution of herpes zoster (shingles) lesions usually enable a clinical diagnosis to be made easily. Herpes zoster and postherpetic neuralgia occur mainly in older patients.
Nursing March 2012 Daniel A. Hussar	New Drugs 2012: part I In this article, you'll learn about 11 recently approved drugs.
American Family Physician March 15, 2002 Caroline M. Rudnick & Grant S. Hoekzema	Neonatal Herpes Simplex Virus Infections Neonatal herpes simplex virus infections can result in serious morbidity and mortality...
Nurse Practitioner February 2012 Jennifer M. Belavic	Annual drug update 2011 in review Many new medications were approved throughout 2011. This article will cover a variety of drugs that will be useful in nurse practitioner practice
Nursing February 2010 Daniel A. Hussar	New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs.
Nursing June 2010 Daniel A. Hussar	New drugs 2010, part 2 In this article, you'll learn about 14 recently marketed new drugs.
American Family Physician May 1, 2003 Miller et al.	Update on the Prevention and Treatment of Sexually Transmitted Diseases The Centers for Disease Control and Prevention (CDC) recently published updated guidelines that provide new strategies for the prevention and treatment of sexually transmitted diseases (STDs).
Nursing February 2009 Daniel A. Hussar	New Drugs 09: Part 1 Learn about 10 new drugs, including nebivolol HCl, the newest beta-adrenergic blocking agent for hypertension.
Nursing June 2011 Daniel A. Hussar	New Drugs 2011: Part 2 In this article, you'll learn about seven recently approved drugs, including: fingolimod hydrochloride, an oral drug indicated to treat patients with relapsing forms of multiple sclerosis.
American Family Physician January 15, 2003 Gregory H. Taylor	Cytomegalovirus Cytomegalovirus (CMV) is a prevalent viral pathogen. The majority of persons with acute CMV will experience an inapparent infection. Complications of acute CMV infection in immunocompetent persons are rare, except in newborns.
American Family Physician December 1, 2000 Norman J. Montalto	Updated Treatment for Influenza A and B The prevention of influenza is best accomplished with a broad-based immunization program...
The Motley Fool August 10, 2010 Ryan McBride	Vertex's Telaprevir Clears Hurdle, Could Halve Treatment Times for Hepatitis C Study results are positive.
Nursing January 2011 Carl A. Kirton	HIV: The Changing Epidemic Since its emergence in the early 1980s, HIV infection in the United States has evolved from an acute debilitating condition to a chronic, treatable illness.
American Family Physician November 1, 2002 Shaikh & Ta	Evaluation and Management of Herpes Zoster Ophthalmicus Timely diagnosis and management of herpes zoster ophthalmicus, with referral to an ophthalmologist when ophthalmic involvement is present, are critical in limiting visual morbidity.
American Family Physician January 15, 2006 Ann M. Khalsa	Preventive Counseling, Screening, and Therapy for the Patient with Newly Diagnosed HIV Infection The epidemic of HIV continues, and the infection is converting into a treatable chronic disease; therefore, it is increasingly important for family physicians to be current with and comfortable in providing basic care to patients infected with HIV.
American Family Physician February 15, 2003	Antiviral Drugs in the Immunocompetent Host: Part II. Treatment of Influenza and Respiratory Syncytial Virus Infections
American Family Physician November 1, 2001 Thomas R. Riley	Preventive Strategies in Chronic Liver Disease Chronic liver disease is the 10th leading cause of death in the United States. Preventive care can significantly reduce the progression of liver disease. Part I: Alcohol, Vaccines, Toxic Medications and Supplements, Diet and Exercise...
American Family Physician June 15, 2006 Brundage & Fitzpatrick	Hepatitis A The introduction of hepatitis A vaccines in 1995 led to a drop in the number of reported cases of hepatitis A and a shift to a higher percentage of cases occurring in older age groups. The hepatitis A virus survives for extended periods in the environment.
Nurse Practitioner February 2011 Jennifer M. Belavic	Annual Drug Update: 2010 in Review In 2010, the FDA approved several new drugs and new indications for use in primary care. From new therapies for adults with rheumatoid arthritis to a combination drug for benign prostatic hyperplasia, NPs need to be aware of the latest medications now available.
The Motley Fool September 7, 2010 Luke Timmerman	Vertex Nails Third Big Trial With Hepatitis C Drug And in the toughest patients to treat, too.
American Family Physician January 15, 2001 Charles P. Mouton	Common Infections in Older Adults Despite advances in antibiotic therapy, infectious diseases continue to be a major cause of mortality in older adults. The diagnostic and therapeutic nuances of managing infections in older adults create special challenges for physicians...
Chemistry World April 21, 2010 Sarah Houlton	Fresh hep C hope A new kind of compound to treat hepatitis C is showing promise in early clinical trials.
The Motley Fool April 25, 2011 Luke Timmerman	Vertex, Merck Step Up to the Public Stage With Hepatitis C Drugs This Week Most analysts see Vertex's drug as best-in-class. But what does the FDA have to say about it?
American Family Physician April 15, 2005 Kirkham, Harris & Grzybowski	Evidence-Based Prenatal Care: Part II. Third-Trimester Care and Prevention of Infectious Diseases Recommendations for care, disease screening, labor induction and vaccinations for patients during late pregnancy.
Pharmaceutical Executive December 1, 2010 Walter Armstrong	Hepatitis C: Another Protease Revolution The launch of a new class of protease inhibitors is set to transform HCV treatment over the next decade, with kinder, gentler oral antiviral cocktails that will increase success rates from 50 percent to 75 percent.
American Family Physician November 15, 2004 Peter A. Calabresi	Diagnosis and Management of Multiple Sclerosis The diagnosis of multiple sclerosis should be made by a physician with experience in identifying the disease. Five disease-modifying treatments for multiple sclerosis have been approved by the U.S. Food and Drug Administration.
American Family Physician February 15, 2007 Gonsalves et al.	Common Oral Lesions: Part I. Superficial Mucosal Lesions Physicians regularly encounter oral health issues in practice. This article, part I of a two-part series, reviews superficial mucosal lesions: candidiasis, herpes labialis, aphthous stomatitis, erythema migrans, hairy tongue, and lichen planus.
American Family Physician September 1, 2004 Ostapchuk, Roberts & Haddy	Community-Acquired Pneumonia in Infants and Children When diagnosing community-acquired pneumonia, physicians should rely mainly on the patient's history and physical examination, supplemented by judicious use of chest radiographs and laboratory tests as needed.
The Motley Fool May 17, 2010 Luke Timmerman	Vertex Awaits Final Proof that Hepatitis C Drug Works For this drug researcher, the proof is in the telaprevir.
The Motley Fool July 27, 2011 Alexander Crawford	Vertex Moving Closer to a Cure for Hepatitis C How do you think the treatment of hepatitis C will evolve?
Chemistry World December 9, 2009 Sarah Houlton	New hep C breakthrough A drug being developed by Denmark's Santaris Pharma could provide a breakthrough in the treatment of hepatitis C, and positive results in a study on chimpanzees point to its potential to avoid drug resistance.
American Family Physician January 1, 2004	Hepatitis B Infection What is hepatitis B virus?... How can I tell if I have HBV infection?... What happens after HBV infection?... What health problems can chronic HBV infection cause?... How can I protect my liver if I have chronic HBV infection?... How can HBV infection be prevented?... etc.
American Family Physician April 15, 2006 Karl E. Miller	Diagnosis and Treatment of Chlamydia trachomatis Infection Chlamydia trachomatis infection most commonly affects the urogenital tract. In men, the infection usually is symptomatic, with dysuria and a discharge from the penis. Most women with chlamydial infection have minimal or no symptoms, but some develop pelvic inflammatory disease.
The Motley Fool April 19, 2005 Charly Travers	A Rising Star in Biotech Idenix is following a proven path to success: novel drug development. This is one biotech to keep on your watch list for the next year.
American Family Physician March 15, 2002	Herpes During Pregnancy--What It Means, What to Expect What is a genital herpes infection?... What if I have herpes and become pregnant?... What if I get herpes during pregnancy?... Where can I find more information on genital herpes infections?...
Nursing May 2009 Davenport & Myers	How to Protect Yourself After Body Fluid Exposure Here's how you can minimize the risk of disease transmission if you or a coworker is accidentally exposed to blood or another potentially infectious body fluid.
Chemistry World August 20, 2009 Sarah Houlton	Testing times: predicting hep C response A finding by David Goldstein and his group at Duke University in the US may make it possible to predict which patients are likely to benefit from the drugs, and which will probably suffer the nasty side-effects without much chance of success.
American Family Physician September 1, 2006 Heidelbaugh & Bruderly	Cirrhosis and Chronic Liver Failure: Part I. Diagnosis and Evaluation Part I of a two-part on how to diagnose and determine treatment for cirrhosis and chronic liver failure.
American Family Physician March 15, 2004	Hepatitis C What is hepatitis C? How is it spread?
The Motley Fool August 11, 2010 Brian Orelli	Dang! This Drug Is Shining Brighter Vertex illuminates telaprevir's additional benefit in treating hepatitis C patients.
American Family Physician May 1, 2003 O'Brien & Halverson	Recognition and Management of Bioterrorism Infections Familiarity with the infectious agents of highest priority can expedite diagnosis and initial management, and lead to a successful public health response to such an attack.
The Motley Fool October 31, 2007 Brian Lawler	The Next Hepatitis C Blockbuster? Never before have there been so many new drugs in development to treat Hepatitis C. Which companies have the compounds most likely to win this race? Investors, take note.